Affigen Email Format

Biotechnology ResearchMissouri, United States2-10 Employees

Affigen is a translational-stage biotechnology company based in St. Louis, Missouri, developing therapies that identify and target molecules unique to cancer. Its approach seeks to provoke immune responses against tumor-associated proteins while sparing healthy tissues through careful design. The company relies on highly automated process engineering and tailored biologics manufacturing to advance treatments for targets that have been difficult to address, working in collaboration with a network of academic researchers.

The work centers on proteins that differentiate malignant cells from their normal counterparts, enabling precise, targeted destruction of cancer cells. With a small team and a translational focus, Affigen collaborates with academic partners to move its therapies toward clinical testing.

Sign up for free to view info

Company overview Employee directory